相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
Matthias Eiber et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
Martina Weineisen et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer
Markus Dietlein et al.
MOLECULAR IMAGING AND BIOLOGY (2015)
Twins in spirit - episode I: comparative preclinical evaluation of [68Ga]DOTATATE and [68Ga]HA-DOTATATE
Margret Schottelius et al.
EJNMMI RESEARCH (2015)
[68Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice
Thomas Krohn et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Cationic eluate pretreatment for automated synthesis of [68Ga]CPCR4.2
Rene Martin et al.
NUCLEAR MEDICINE AND BIOLOGY (2014)
Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer
Matthias Eder et al.
PHARMACEUTICALS (2014)
New prospects for PET in prostate cancer imaging: a physicist's viewpoint
Maurizio Conti
EJNMMI PHYSICS (2014)
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
A. Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Matthias Eder et al.
BIOCONJUGATE CHEMISTRY (2012)
International Variation in Prostate Cancer Incidence and Mortality Rates
Melissa M. Center et al.
EUROPEAN UROLOGY (2012)
Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
S. Schwarzenboeck et al.
THERANOSTICS (2012)
Impact of Time-of-Flight on PET Tumor Detection
Dan J. Kadrmas et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Impact of dual-time-point 18F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules
Khaled Alkhawaldeh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Dual time point 2-[18F]fluoro-2′-deoxyglucose positron emission tomography in chronic bacterial ostelomyelitis
CO Sahlmann et al.
NUCLEAR MEDICINE COMMUNICATIONS (2004)
A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen
SA Rajasekaran et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy
JF Ward et al.
JOURNAL OF UROLOGY (2003)
分享论文
